Amino acid differences in glycoproteins B (Gb), C (gC), H (gH) and L(gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α

Virology Journal

Volumn 9, Issue 1, 2012, Pages

  Chowdhury, Sona ^a   Naderi, Misagh ^a   Chouljenko, Vladimir N ^a   Walker, Jason D ^a   Kousoulas, Konstantin G ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CELL RECEPTOR; GLYCOPROTEIN B; GLYCOPROTEIN H; GLYCOPROTEIN L; HEPARAN SULFATE; HERPESVIRUS ENTRY MEDIATOR; MEMBRANE PROTEIN; MEMBRANE PROTEIN UL20; NECTIN 1; PAIRED IMMUNOGLOBULIN LIKE TYPE 2 RECEPTOR ALPHA; PROLINE; PROTEIN C; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; IMMUNOGLOBULIN RECEPTOR; PILRA PROTEIN, HUMAN; VIRUS DNA; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL FUSION; CELL MEMBRANE; CHO CELL LINE; FEMALE; HERPES SIMPLEX VIRUS 1 (STRAIN ANG); HERPES SIMPLEX VIRUS 1 (STRAIN F); HERPES SIMPLEX VIRUS 1 (STRAIN H129); HERPES SIMPLEX VIRUS 1 (STRAIN KOS); HERPES SIMPLEX VIRUS 1 (STRAIN MCKRAE); HUMAN ALPHAHERPESVIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; VERO CELL LINE; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS GENE; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; CELL LINE; CHEMISTRY; DNA SEQUENCE; GENETICS; HERPES SIMPLEX VIRUS 1; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

ANIMALS; CELL LINE; DNA, VIRAL; GLYCOPROTEINS; HERPESVIRUS 1, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, IMMUNOLOGIC; SEQUENCE ANALYSIS, DNA; VIRAL STRUCTURAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84862238803     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-112     Document Type: Article

References (57)

1. Fisman DN, Lipsitch M, Hook EW, Goldie SJ: Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm Dis 2002, 29:608-622.
2. Stahl JP, Mailles A, Dacheux L, Morand P: Epidemiology of viral encephalitis in 2011. Med Mal Infect 2011, 41:453-464.
3. Steiner I: Herpes simplex virus encephalitis: new infection or reactivation? Curr Opin Neurol 2011, 24:268-274.
4. Zamora MR: DNA viruses (CMV, EBV, and the herpesviruses). Semin Respir Crit Care Med 2011, 32:454-470.
5. Whitley RJ, Kimberlin DW, Roizman B: Herpes simplex viruses. Clin Infect Dis 1998, 26:541-553, quiz 554-545.
6. Whitley R: Herpes Simplex Viruses. In Fields Virology. Edited by: Knipe D, Howley P. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:2461-2510.
7. Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM: Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989, 107:1155-1159.
8. Liesegang TJ: Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 20:1-13.
9. Herold BC, WuDunn D, Soltys N, Spear PG: Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 1991, 65:1090-1098.
10. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG: Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 1998, 280:1618-1620.
11. Montgomery RI, Warner MS, Lum BJ, Spear PG: Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996, 87:427-436.
12. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG: A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999, 99:13-22.
13. Satoh T, Arii J, Suenaga T, Wang J, Kogure A, Uehori J, Arase N, Shiratori I, Tanaka S, Kawaguchi Y, et al: PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 2008, 132:935-944.
14. Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, Kawaguchi Y: Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 2010, 467:859-862.
15. Suenaga T, Satoh T, Somboonthum P, Kawaguchi Y, Mori Y, Arase H: Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc Natl Acad Sc USA 2010, 107:866-871.
16. Hannah BP, Heldwein EE, Bender FC, Cohen GH, Eisenberg RJ: Mutational evidence of internal fusion loops in herpes simplex virus glycoprotein B. J Virol 2007, 81:4858-4865.
17. Heldwein EE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, Harrison SC: Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006, 313:217-220.
18. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R: Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol 2011, 9:369-381.
19. Hill JM, Rayfield MA, Haruta Y: Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res 1987, 6:91-97.
20. Hill TJ: Ocular pathogenicity of herpes simplex virus. Curr Eye Res 1987, 6:1-7.
21. Perng GC, Mott KR, Osorio N, Yukht A, Salina S, Nguyen QH, Nesburn AB, Wechsler SL: Herpes simplex virus type 1 mutants containing the KOS strain ICP34.5 gene in place of the McKrae ICP34.5 gene have McKraelike spontaneous reactivation but non-McKrae-like virulence. J Gen Virol 2002, 83:2933-2942.
22. Kosovsky J, Vojvodova A, Oravcova I, Kudelova M, Matis J, Rajcani J: Herpes simplex virus 1 (HSV-1) strain HSZP glycoprotein B gene: comparison of mutations among strains differing in virulence. Virus Genes 2000, 20:27-33.
23. Cameron JM, McDougall I, Marsden HS, Preston VG, Ryan DM, Subak- Sharpe JH: Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol 1988, 69(Pt 10):2607-2612.
24. Gordon YJ, Simon PL, Armstrong JA: Neurovirulence of an herpes simplex type 1 thymidine kinase negative mutant determined by virus biochemical defect and host immune system in mice. Brief report. Arch Virol 1984, 80:225-229.
25. Kurachi R, Daikoku T, Tsurumi T, Maeno K, Nishiyama Y, Kurata T: The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice. Arch Virol 1993, 133:259-273.
26. Nishiyama Y, Kurachi R, Daikoku T, Umene K: The US 9, 10, 11, and 12 genes of herpes simplex virus type 1 are of no importance for its neurovirulence and latency in mice. Virology 1993, 194:419-423.
27. Perng GC, Thompson RL, Sawtell NM, Taylor WE, Slanina SM, Ghiasi H, Kaiwar R, Nesburn AB, Wechsler SL: An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J Virol 1995, 69:3033-3041.
28. Imai T, Arii J, Minowa A, Kakimoto A, Koyanagi N, Kato A, Kawaguchi Y: Role of the herpes simplex virus 1 Us3 kinase phosphorylation site and endocytosis motifs in the intracellular transport and neurovirulence of envelope glycoprotein B. J Virol 2011, 85:5003-5015.
29. Yuhasz SA, Stevens JG: Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness. J Virol 1993, 67:5948-5954.
30. Rajcani J, Kudelova M: Glycoprotein K of herpes simplex virus: a transmembrane protein encoded by the UL53 gene which regulates membrane fusion. Virus Genes 1999, 18:81-90.
31. Mott KR, Chentoufi AA, Carpenter D, BenMohamed L, Wechsler SL, Ghiasi H: The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity. Invest Ophthalmol Vis Sci 2009, 50:2903-2912.
32. Mott KR, Perng GC, Osorio Y, Kousoulas KG, Ghiasi H: A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice. J Virol 2007, 81:12962-12972.
33. Osorio Y, Mott KR, Jabbar AM, Moreno A, Foster TP, Kousoulas KG, Ghiasi H: Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK. Virus Res 2007, 128:71-80.
34. David AT, Baghian A, Foster TP, Chouljenko VN, Kousoulas KG: The herpes simplex virus type 1 (HSV-1) glycoprotein K(gK) is essential for viral corneal spread and neuroinvasiveness. Curr Eye Res 2008, 33:455-467.
35. Foster TP, Rybachuk GV, Kousoulas KG: Glycoprotein K specified by herpes simplex virus type 1 is expressed on virions as a Golgi complexdependent glycosylated species and functions in virion entry. J Virol 2001, 75:12431-12438.
36. Jambunathan N, Chowdhury S, Subramanian R, Chouljenko VN, Walker JD, Kousoulas KG: Site-specific proteolytic cleavage of the amino terminus of herpes simplex virus glycoprotein K on virion particles inhibits virus entry. J Virol 2011, 85:12910-12918.
37. Hutchinson L, Roop-Beauchamp C, Johnson DC: Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. J Virol 1995, 69:4556-4563.
38. Foster TP, Kousoulas KG: Genetic analysis of the role of herpes simplex virus type 1 glycoprotein K in infectious virus production and egress. J Virol 1999, 73:8457-8468.
39. Jayachandra S, Baghian A, Kousoulas KG: Herpes simplex virus type 1 glycoprotein K is not essential for infectious virus production in actively replicating cells but is required for efficient envelopment and translocation of infectious virions from the cytoplasm to the extracellular space. J Virol 1997, 71:5012-5024.
40. Chouljenko VN, Iyer AV, Chowdhury S, Chouljenko DV, Kousoulas KG: The amino terminus of herpes simplex virus type 1 glycoprotein K (gK) modulates gB-mediated virus-induced cell fusion and virion egress. J Virol 2009, 83:12301-12313.
41. Chouljenko VN, Iyer AV, Chowdhury S, Kim J, Kousoulas KG: The herpes simplex virus type 1 UL20 protein and the amino terminus of glycoprotein K (gK) physically interact with gB. J Virol 2010, 84:8596-8606.
42. Melancon JM, Fulmer PA, Kousoulas KG: The herpes simplex virus UL20 protein functions in glycoprotein K (gK) intracellular transport and virusinduced cell fusion are independent of UL20 functions in cytoplasmic virion envelopment. Virol J 2007, 4:120.
43. Melancon JM, Luna RE, Foster TP, Kousoulas KG: Herpes simplex virus type 1 gK is required for gB-mediated virus-induced cell fusion, while neither gB and gK nor gB and UL20p function redundantly in virion deenvelopment. J Virol 2005, 79:299-313.
44. Wang J, Fan Q, Satoh T, Arii J, Lanier LL, Spear PG, Kawaguchi Y, Arase H: Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 receptor alpha depends on specific sialylated O-linked glycans on gB. J Virol 2009, 83:13042-13045.
45. Fan Q, Lin E, Satoh T, Arase H, Spear PG: Differential effects on cell fusion activity of mutations in herpes simplex virus 1 glycoprotein B (gB) dependent on whether a gD receptor or a gB receptor is overexpressed. J Virol 2009, 83:7384-7390.
46. Lin E, Spear PG: Random linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein B. Proc Natl Acad Sci USA 2007, 104:13140-13145.
47. Tabata S, Kuroki K, Wang J, Kajikawa M, Shiratori I, Kohda D, Arase H, Maenaka K: Biophysical characterization of O-glycosylated CD99 recognition by paired Ig-like type 2 receptors. J Biol Chem 2008, 283:8893-8901.
48. Wang J, Shiratori I, Satoh T, Lanier LL, Arase H: An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR). J Immunol 2008, 180:1686-1693.
49. Williamson MP: The structure and function of proline-rich regions in proteins. Biochem J 1994, 297(Pt 2):249-260.
50. Fan Q, Lin E, Spear PG: Insertional mutations in herpes simplex virus type 1 gL identify functional domains for association with gH and for membrane fusion. J Virol 2009, 83:11607-11615.
51. Chowdary TK, Cairns TM, Atanasiu D, Cohen GH, Eisenberg RJ, Heldwein EE: Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL. Nat Struct Mol Biol 2010, 17:882-888.
52. Cardin AD, Weintraub HJ: Molecular modeling of proteinglycosaminoglycan interactions. Arteriosclerosis 1989, 9:21-32.
53. Trybala E, Roth A, Johansson M, Liljeqvist JA, Rekabdar E, Larm O, Bergstrom T: Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1. Virology 2002, 302:413-419.
54. Tal-Singer R, Peng C, Ponce De Leon M, Abrams WR, Banfield BW, Tufaro F, Cohen GH, Eisenberg RJ: Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol 1995, 69:4471-4483.
55. Trybala E, Bergstrom T, Svennerholm B, Jeansson S, Glorioso JC, Olofsson S: Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol 1994, 75(Pt 4):743-752.
56. Fan Q, Longnecker R: The Ig-like v-type domain of paired Ig-like type 2 receptor alpha is critical for herpes simplex virus type 1-mediated membrane fusion. J Virol 2010, 84:8664-8672.
57. Shah A, Farooq AV, Tiwari V, Kim MJ, Shukla D: HSV-1 infection of human corneal epithelial cells: receptor-mediated entry and trends of reinfection. Mol Vis 2010, 16:2476-2486.